Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series

Immune-mediated necrotizing myopathy (IMNM) is a group of immune-related myopathies characterized by progressive proximal muscle weakness, extremely high serum creatine kinase (CK) levels, and necrotic muscle fibers with a relative lack of inflammation. Treatment of IMNM is challenging, with most ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Neurol Disord
Egile Nagusiak: Xiong, Anji, Yang, Guancui, Song, Zhuoyao, Xiong, Chen, Liu, Deng, Shuai, Yu, He, Linqian, Zhang, Liangwen, Guo, Zepeng, Shuai, Shiquan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2021
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958167/
https://ncbi.nlm.nih.gov/pubmed/33786066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286421998918
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak